Abstract
Background Hypertension is a health issue that affects more than one billion people worldwide and can lead to severe health complications. If untreated, hypertensive crises can occur, which are medical emergencies that require immediate care. Remote Patient Monitoring (RPM) offers a transformative approach to managing hypertension by enabling continuous collection and analysis of blood pressure (BP) data. Our study focuses on Withings’ RPM system and analyzes the outcomes and engagement patterns of patients using RPM for hypertension management.
Methods The study comprises 1,873 patients over 6 months who followed an RPM program and used Withings Blood Pressure Monitors. Data was analyzed using Python and R. The analysis examines patients’ systolic and diastolic BP over time as well as the frequency of measurements that patients took using the RPM system.
Results The study reveals that patients who consistently followed the program experienced significant reductions in both systolic and diastolic BP levels. Statistically significant reductions in SBP were observed in users with higher grades of hypertension over six months. The percentage of users experiencing hypertensive crises was reduced from more than 8% to less than 3% over 24 weeks. More frequent engagement with the RPM program was associated with greater BP reductions.
Conclusion These findings highlight the potential of RPM programs in helping patients manage hypertension and minimize hypertensive crises. Future research should go further to understand factors that impact patient outcomes and engagement patterns to improve the effectiveness of RPM programs.
Competing Interest Statement
Withings is the manufacturer and developer of the Blood Pressure Monitor used and this study was conducted by Withings researchers. Even if the publication does not make any explicit claims about the performance of Withings devices, the authors declare a potential conflict of interest, as the findings of this study may have implications for the acceptance and use of the companys products and services.
Funding Statement
This work was entirely supported by Withings.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data used in this analysis is secondary data that was taken throughout the regular course of care by Withings partners using the RPM program. All data has been aggregated and anonymized in this analysis to comply with HIPAA as well as European data protection regulations (27,28). Since the data were aggregated and contained no personal identifiers or protected health information, the involvement of an ethical committee was not required. The use of data in this study was overseen by the Withings Data Protection Officer to ensure adherence to privacy protection standards.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
